Patents by Inventor Jay Shawn Kimbro

Jay Shawn Kimbro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA
    Publication number: 20210322510
    Abstract: The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: OSA or OSA induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in OSA patients by administering oxytocin.
    Type: Application
    Filed: November 18, 2020
    Publication date: October 21, 2021
    Inventors: David MENDELOWITZ, Vivek JAIN, Heather JAMESON, Jay Shawn KIMBRO
  • Oxytocin improves treatment of obstructive sleep apnea
    Patent number: 10842845
    Abstract: The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: OSA or OSA induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in OSA patients by administering oxytocin.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: November 24, 2020
    Assignee: THE GEORGE WASHINGTON UNIVERSITY
    Inventors: David Mendelowitz, Vivek Jain, Heather Jameson, Jay Shawn Kimbro
  • OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA
    Publication number: 20190076501
    Abstract: The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: OSA or OSA induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in OSA patients by administering oxytocin.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Inventors: David MENDELOWITZ, Vivek JAIN, Heather JAMESON, Jay Shawn KIMBRO
  • Oxytocin improves treatment of obstructive sleep apnea
    Patent number: 10166268
    Abstract: The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: OSA or OSA induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in OSA patients by administering oxytocin.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: January 1, 2019
    Assignee: THE GEORGE WASHINGTON UNIVERSITY
    Inventors: David Mendelowitz, Vivek Jain, Heather Jameson, Jay Shawn Kimbro
  • OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA
    Publication number: 20170143790
    Abstract: The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: OSA or OSA induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in OSA patients by administering oxytocin.
    Type: Application
    Filed: July 2, 2015
    Publication date: May 25, 2017
    Inventors: David Mendelowitz, Vivek Jain, Heather Jameson, Jay Shawn Kimbro